A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes
- PMID: 23795223
- PMCID: PMC3685201
- DOI: 10.1016/j.jgo.2012.12.005
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes
Abstract
Objectives: To develop and provide initial validation for amultivariate, claims-based prediction model for disability status (DS), a proxymeasure of performance status (PS), among older adults. The model was designed to augment information on health status at the point of cancer diagnosis in studies using insurance claims to examine cancer treatment and outcomes.
Materials and methods: We used data from the 2001–2005 Medicare Current Beneficiary Survey (MCBS), with observations randomly split into estimation and validation subsamples. We developed an algorithm linking self-reported functional status measures to a DS scale, a proxy for the Eastern Cooperative Oncology Group (ECOG) PS scale. The DS measure was dichotomized to focus on good [ECOG 0–2] versus poor [ECOG 3–4] PS. We identified potential claims-based predictors, and estimated multivariate logistic regression models, with poor DS as the dependent measure, using a stepwise approach to select the optimal model. Construct validity was tested by determining whether the predicted DS measure generated by the model was a significant predictor of survival within a validation sample from the MCBS.
Results and conclusion: One-tenth of the beneficiaries met the definition for poor DS. The base model yielded high sensitivity (0.79) and specificity (0.92); positive predictive value=48.3% and negative predictive value=97.8%, c-statistic=0.92 and good model calibration. Adjusted poor claims-based DS was associated with an increased hazard of death (HR=3.53, 95% CI 3.18, 3.92). The ability to assess DS should improve covariate control and reduce indication bias in observational studies of cancer treatment and outcomes based on insurance claims.
Similar articles
-
Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studies.Med Care. 2014 Jun;52(6):500-10. doi: 10.1097/MLR.0000000000000122. Med Care. 2014. PMID: 24638118 Free PMC article.
-
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.Lung Cancer. 2015 Jan;87(1):59-64. doi: 10.1016/j.lungcan.2014.10.011. Epub 2014 Nov 13. Lung Cancer. 2015. PMID: 25443272
-
Development and validation of a claims-based approach to proxy ECOG performance status across ten tumor groups.J Comp Eff Res. 2018 Mar;7(3):193-208. doi: 10.2217/cer-2017-0040. Epub 2018 Mar 13. J Comp Eff Res. 2018. PMID: 29533694
-
Predicting Disability among Community-Dwelling Medicare Beneficiaries Using Claims-Based Indicators.Health Serv Res. 2016 Feb;51(1):262-81. doi: 10.1111/1475-6773.12316. Epub 2015 May 25. Health Serv Res. 2016. PMID: 26015332 Free PMC article.
-
A cardiovascular disease risk prediction algorithm for use with the Medicare current beneficiary survey.Health Serv Res. 2020 Aug;55(4):568-577. doi: 10.1111/1475-6773.13290. Epub 2020 Apr 14. Health Serv Res. 2020. PMID: 32285938 Free PMC article.
Cited by
-
The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC.Immunotherapy. 2024;16(16-17):1057-1068. doi: 10.1080/1750743X.2024.2394382. Epub 2024 Sep 13. Immunotherapy. 2024. PMID: 39268919
-
Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases.Transl Lung Cancer Res. 2024 Jul 30;13(7):1620-1634. doi: 10.21037/tlcr-24-205. Epub 2024 Jul 25. Transl Lung Cancer Res. 2024. PMID: 39118898 Free PMC article.
-
Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data.Drugs Aging. 2024 Jul;41(7):583-600. doi: 10.1007/s40266-024-01121-0. Epub 2024 Jul 2. Drugs Aging. 2024. PMID: 38954400 Review.
-
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study.J Geriatr Oncol. 2024 Jun;15(5):101774. doi: 10.1016/j.jgo.2024.101774. Epub 2024 Apr 26. J Geriatr Oncol. 2024. PMID: 38676975
-
Association of cancer diagnosis with disability status among older survivors of colorectal cancer: a population-based retrospective cohort study.Front Oncol. 2024 Mar 15;14:1283252. doi: 10.3389/fonc.2024.1283252. eCollection 2024. Front Oncol. 2024. PMID: 38559557 Free PMC article.
References
-
- Dreyer NA, Tunis SR, Berger M, Ollendorf D, Mattox P, Gliklich R. Why observational studies should be among the tools used in comparative effectiveness research. Health Aff (Millwood) 2010;29:1818–1825. - PubMed
-
- Fleurence RL, Naci H, Jansen JP. The critical role of observational evidence in comparative effectiveness research. Health Aff (Millwood) 2010;29:1826–1833. - PubMed
-
- Potosky ALM, Riley GFM, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31:749–756. - PubMed
-
- Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(IV):3–18. - PubMed
-
- Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40(IV):26–35. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
